Table 4.
Daily mean insulin dose according to HbA1c levels in the insulin glargine only cohort (N = 158∗).
| Daily mean insulin dose (IU) | Total | |||||
|---|---|---|---|---|---|---|
| <20 IU | 20 IU-29 IU | 30 IU-39 IU | ≥40 IU | |||
| Last HbA1c during follow-up (%) | <7.0% | 46.7 | 33.3 | 58.3 | 63.1 | 53.8 |
| ≥7.0% < 8.0% | 25.3 | — | 16.7 | 15.4 | 19.6 | |
| ≥8.0% < 9.0% | 17.3 | 33.3 | 8.3 | 9.2 | 13.9 | |
| ≥9.0% | 10.7 | 33.3 | 16.7 | 12.3 | 12.7 | |
∗The analysis was carried out on the cohort of patients for which laboratory data were available and with at least 3 months of follow-up. The last value of HbA1c during the follow-up period was considered. p = 0.256 among different levels of HbA1c and daily mean insulin dose.